BSE: GLAND - Gland Pharma Limited

Rentabilité sur six mois: 0%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Gland Pharma Limited


À propos de l'entreprise Gland Pharma Limited

Gland Pharma Limited, a generic injectable-focused company, engages in the development, manufacture, sale, and distribution of pharmaceuticals. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others.

plus de détails
It offers its products for various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, as well as anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business-to-business model in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

ISIN INE068V01023
Валюта inr
Сайт https://www.glandpharma.com
Цена ао 2449.4
Changement de prix par jour: 0% (2449.4)
Changement de prix par semaine: +11.88% (2189.35)
Changement de prix par mois: +7.07% (2287.7)
Changement de prix sur 3 mois: 0% (2449.4)
Changement de prix sur six mois: 0% (2449.4)
Changement de prix par an: 0% (2449.4)
Evolution du prix sur 3 ans: 0% (2449.4)
Evolution du prix sur 5 ans: 0% (2449.4)
Evolution des prix sur 10 ans: 0% (2449.4)
Evolution des prix depuis le début de l'année: +1.99% (2401.5)

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficacité

Nom Signification Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % 0 0
Rentabilité EPS, % 0 0
Total: 0



Adresse: India, Hyderabad, Plot No. 11 & 84. TSIIC Phase: IV - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.glandpharma.com